查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601595

導管及積極嵌入式設備的CDMO的全球市場:服務範疇·終端用戶·不同地區的預測 (～2032年)

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category, By End-Users And By Region -Market Forecast Till 2032
出版日期: | 出版商: Market Research Future | 英文 187 Pages | 訂單完成後即時交付

價格

導管與主動植入器材 CDMO 市場規模預計將從 2023 年的 69.2 億美元成長到 2024 年的 74.9 億美元，預測期內複合年增長率為 10.82%，到 2032 年預計將成長到188億美元。

市場擴張是由與導管和主動植入設備 CDMO 相關的策略性舉措的增加以及製造外包的增加所推動的。

不斷湧現的舉措正在推動技術創新、改善市場准入並顯著提振市場。策略併購使組織能夠提供全面的解決方案，匯集資源和知識來加速產品開發。同時，醫療基礎設施投資的增加，尤其是在新興國家，以及對微創手術的日益偏好，正在增加先進導管和植入式設備的使用。

區域洞察

北美地區在 2023 年佔據最大的市場佔有率，預計在預測期內將會成長。同時，預計亞太地區在預測期內將以最快的複合年增長率成長。

由於技術發展、有利的監管環境和不斷增長的醫療保健需求，北美市場正在迅速擴張。此外，該市場是由先進的醫療基礎設施和研發方面的大量投資推動的，這使得尖端植入設備的開發成為可能。此外，向新興國家的潛在擴張、個人化治療的興起以及對微創解決方案的需求都指向了成長路徑。

由於技術進步和不斷增長的醫療保健需求，歐洲市場具有巨大的成長潛力。下一代心臟起搏器、神經刺激器和胰島素幫浦等植入式設備技術的進步正在推動對專業製造能力的需求。由於人口老化，慢性病的發生率不斷增加，這也增加了對複雜、高品質植入式治療的需求。

亞太市場出現了顯著成長，預計將成為預測期內成長最快的地區。幾個關鍵推動因素正在推動強勁成長。中國、印度和日本等國家醫療技術的快速進步和醫療基礎設施投資的增加正在推動對先進植入設備的需求。慢性病、糖尿病盛行率的增加以及人口老化正在增加對新療法的需求。

本報告提供全球導管及積極嵌入式設備的CDMO的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

  • 促進因素
    • 增加與導管和主動植入設備 CDMO 相關的策略性舉措
    • 製造外包增加
  • 阻礙因素
    • 嚴格的法規和政策
  • 機會
    • 全球老化
    • 透過 CDMO 擴大設施

第5章 市場要素分析

  • 波特的五力分析
  • COVID-19對市場帶來的影響
  • 市場趨勢

第6章 導管及積極嵌入式設備的CDMO市場:不同服務類別的

  • 概要
  • 導管
    • 心導管
    • 泌尿科導管
    • 神經血管導管
    • 其他
  • 積極嵌入式設備
    • 神經調節設備
    • 結構的心臟設備
    • 心臟衰竭設備
    • 泌尿科用嵌入式設備
    • 其他
  • 內視鏡設備
  • 其他

第7章 導管及積極嵌入式設備的CDMO市場:各終端用戶

  • 概要
  • 醫療設備OEM企業
  • 學術研究機關
  • 政府機關

第8章 導管及積極嵌入式設備的CDMO市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 其他地區
    • 中東·非洲
    • 南美

第9章 競爭情形

  • 市場佔有率分析
  • 競爭儀表板
  • 上市公司的股票概要
  • 比較分析:主要企業的財務趨勢
  • 主要的展開與成長策略

第10章 企業簡介

  • INTEGER HOLDINGS CORPORATION
  • CIRTEC
  • BIOMERICS
  • SWITCHBACK MEDICAL
  • VELENTIUM LLC
  • HERAEUS GROUP
  • ZEUS COMPANY LLC
  • VERANEX
  • FREUDENBERG MEDICAL
  • MEDEOLOGIX
  • DATA CITATIONS
Product Code: MRFR/HC/25126-CR

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, and Others), By End-Users (Medical Device OEM Companies, Academic and Research Institutes, and Government Agencies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) -Market Forecast Till 2032

Market Overview

The Catheters and Active Implantable CDMO Market was valued at USD 6.92 billion in 2023. The market is expected to increase from USD 7.49 billion in 2024 to USD 18.8 billion by 2032, with a compound annual growth rate (CAGR) of 10.82% for the forecast period (2024-2032).

The market expansion is being driven by increased strategic initiatives connected with catheters and active implantable CDMO, as well as increased production outsourcing.

Growing initiatives are promoting innovation and enhancing market accessibility, significantly boosting the global market for catheters and active implanted CDMOs. Strategic mergers and acquisitions enable organizations to offer comprehensive solutions and accelerate product development by pooling resources and knowledge. Simultaneously, the use of advanced catheters and implantable devices is increasing as a result of increased investments in healthcare infrastructure, particularly in emerging nations, and a growing preference for less intrusive procedures.

Market Segment insights

The Catheters and Active Implantable CDMO Market is divided into three service segments: catheters, active implantable devices, and endoscopy devices.

The Catheters and Active Implantable CDMO Market is divided into three end user segments: medical device OEM firms, academic and research organizations, and government agencies.

Regional insights

North America held the biggest market share in 2023 and is expected to grow over the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR over the forecast period.

The Active Implantable CDMO market in North America is expanding rapidly, owing to technical developments, a favorable regulatory environment, and rising healthcare demands. Furthermore, the market is driven by sophisticated healthcare infrastructure and significant investment in R&D, which allows for the development of cutting-edge implantable devices. Furthermore, potential for development into emerging countries, the rise of customized treatment, and the demand for minimally invasive solutions offer paths for growth.

The Americas region is followed by Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The Active Implantable CDMO market in Europe has great growth potential, driven by technological advancements and rising healthcare demands. Implantable device technology improvements, such as next-generation cardiac pacemakers, neurostimulators, and insulin pumps, are driving up demand for specialized manufacturing capabilities. The rising frequency of chronic diseases, fueled by an aging population, heightens the demand for complex, high-quality implantable treatments.

Asia-Pacific is predicted to show significant growth and is projected to be the fastest growing region throughout the projection period. Several important drivers are driving robust growth. Rapid improvements in medical technology, as well as increased investment in healthcare infrastructure in nations such as China, India, and Japan, are driving demand for advanced implantable devices. The increased prevalence of chronic diseases, diabetes, and an aging population increase the demand for novel remedies.

Major Players

Major competitors in the Catheters and Active Implantable CDMO Market include Integer Holdings Corporation (US), Cirtec (US), Biomerics (US), Switchback Medical (US), Velentium LLC (US), Heraeus Group (Germany), Zeus Company LLC (US), Veranex (US), Freudenberg Medical (US), and Medeologix (Taiwan).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 Data Mining Process
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 Secondary Research data flow:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 Primary Research DATA FLOW:
    • 3.5.2 Primary Research: Number of Interviews conducted
    • 3.5.3 Primary Research: Regional Coverage
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 Revenue Analysis Approach
  • 3.7 DATA FORECASTING
    • 3.7.1 Data forecasting Technique
  • 3.8 DATA MODELING
    • 3.8.1 microeconomic factor analysis:
    • 3.8.2 Data modeling:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 Increasing strategic initiatives associated with Catheters and Active Implantable CDMO
    • 4.2.2 Increased Outsourcing of Manufacturing
  • 4.3 RESTRAINTS
    • 4.3.1 Stringent regulatory Policies
  • 4.4 OPPORTUNITY
    • 4.4.1 Growing geriatric population across the globe
    • 4.4.2 FACILITY EXPANSION by Contract Development Manuacturing Organization

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 Threat of New Entrants
    • 5.1.2 Bargaining Power of Suppliers
    • 5.1.3 Threat of Substitutes
    • 5.1.4 Bargaining Power of Buyers
    • 5.1.5 Intensity of Rivalry
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
  • 5.3 TRENDS IN CDMO FOR CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
    • 5.3.1 Shifting Focus of Medical Device CDMOs to Improve Capabilities

6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY

  • 6.1 OVERVIEW
  • 6.2 CATHETERS
    • 6.2.1 Cardiac Catheters
    • 6.2.2 Urology Catheters
    • 6.2.3 Neurovascular Catheters
    • 6.2.4 Others
  • 6.3 ACTIVE IMPLANTABLE DEVICES
    • 6.3.1 Neuromodulation Devices
      • 6.3.1.1 Spinal Cord Stimulators
      • 6.3.1.2 Deep Brain Stimulators
      • 6.3.1.3 Others
    • 6.3.2 Structural Heart Devices
      • 6.3.2.1 Valve Implants
      • 6.3.2.2 Stents & Shunts
      • 6.3.2.3 Others
    • 6.3.3 Heart Failure Devices
      • 6.3.3.1 Percutaneous Left Ventricular Assist Device (LVAD)
      • 6.3.3.2 Percutaneous Right Ventricular Support Devices (RVAD)
      • 6.3.3.3 Others
    • 6.3.4 Urology Implantable Devices
    • 6.3.5 Others
  • 6.4 ENDOSCOPY DEVICES
  • 6.5 OTHERS

7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 MEDICAL DEVICE OEM COMPANIES
  • 7.3 ACADEMIC AND RESEARCH INSTITUTES
  • 7.4 GOVERNMENT AGENCIES

8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 US
    • 8.2.2 Canada
  • 8.3 EUROPE
    • 8.3.1 Germany
    • 8.3.2 France
    • 8.3.3 UK
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 ASIA-PACIFIC
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 REST OF THE WORLD
    • 8.5.1 Middle East & Africa
    • 8.5.2 South America

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS,
  • 9.3 COMPETITOR DASHBOARD
  • 9.4 PUBLIC PLAYERS STOCK SUMMARY
  • 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.6.1 Facility expansion
    • 9.6.2 Acquisition
    • 9.6.3 Partnership

10 COMPANY PROFILES

  • 10.1 INTEGER HOLDINGS CORPORATION
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 productS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 CIRTEC
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCT OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGIES
  • 10.3 BIOMERICS
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGIES
  • 10.4 SWITCHBACK MEDICAL
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 SWOT ANALYSIS
    • 10.4.6 KEY STRATEGIES
  • 10.5 VELENTIUM LLC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 KEY STRATEGIES
  • 10.6 HERAEUS GROUP
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 SWOT ANALYSIS
    • 10.6.6 KEY STRATEGIES
  • 10.7 ZEUS COMPANY LLC
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 VERANEX
    • 10.8.1 COMPANY OVERVIEw
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 Product OFFERed
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 FREUDENBERG MEDICAL
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 KEY STRATEGIES
  • 10.10 MEDEOLOGIX
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 3 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CARDIAC CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROVASCULAR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 17 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR VALVE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STENTS & SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 22 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE (LVAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS RIGHT VENTRICULAR SUPPORT DEVICES (RVAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ENDOSCOPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR MEDICAL DEVICE OEM COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 34 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 36 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 37 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 38 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 39 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 40 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 41 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 42 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 43 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 44 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 45 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 47 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 48 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 50 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 51 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 53 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 54 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 55 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 58 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 59 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 60 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 61 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 65 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 68 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 70 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 72 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 76 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 79 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 86 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 93 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 94 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 100 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 102 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 108 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 115 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 122 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 129 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 136 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 143 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 150 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 158 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 172 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178 FACILITY EXPANSION
  • TABLE 179 ACQUISITION
  • TABLE 180 PARTNERSHIP
  • TABLE 181 INTEGER HOLDINGS CORPORATION: PRODUCT OFFERED
  • TABLE 182 INTEGER HOLDINGS CORPORATION: KEY DEVELOPMENTS
  • TABLE 183 CIRTEC: PRODUCTS OFFERED
  • TABLE 184 CIRTEC: KEY DEVELOPMENTS
  • TABLE 185 BIOMERICS: PRODUCTS OFFERED
  • TABLE 186 BIOMERICS: KEY DEVELOPMENTS
  • TABLE 187 SWITCHBACK MEDICAL: PRODUCTS OFFERED
  • TABLE 188 VELENTIUM LLC: PRODUCTS OFFERED
  • TABLE 189 HERAEUS GROUP: PRODUCTS OFFERED
  • TABLE 190 ZEUS COMPANY LLC: PRODUCTS OFFERED
  • TABLE 191 VERANEX: PRODUCTS OFFERED
  • TABLE 192 FREUDENBERG MEDICAL: PRODUCTS OFFERED
  • TABLE 193 MEDEOLOGIX: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
  • FIGURE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
  • FIGURE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY SERVICE CATEGORY,
  • FIGURE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY END USER,
  • FIGURE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY REGION,
  • FIGURE 14 NORTH AMERICA MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032
  • FIGURE 15 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 16 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY COUNTRY,
  • FIGURE 17 EUROPE MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
  • FIGURE 18 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 20 ASIA-PACIFIC MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 22 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 23 REST OF THE WORLD MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
  • FIGURE 24 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 27 COMPETITOR DASHBOARD: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
  • FIGURE 28 INTEGER HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 INTEGER HOLDINGS CORPORATION: SWOT ANALYSIS
  • FIGURE 30 CIRTEC: SWOT ANALYSIS
  • FIGURE 31 SWITCHBACK MEDICAL: SWOT ANALYSIS
  • FIGURE 32 HERAEUS GROUP: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 33 HERAEUS GROUP: SWOT ANALYSIS
  • FIGURE 34 ZEUS COMPANY LLC: SWOT ANALYSIS